Comprehensive Therapy

, Volume 28, Issue 4, pp 200–206

Effects of thiazolidinediones on cardiovascular risk factors

  • Biswanath P. Gouda
  • Sunil Asnani
  • Vivian A. Fonseca
Original Article

DOI: 10.1007/s12019-002-0018-8

Cite this article as:
Gouda, B.P., Asnani, S. & Fonseca, V.A. Compr Ther (2002) 28: 200. doi:10.1007/s12019-002-0018-8

Abstract

The thiazolidinediones are the insulin sensitizers used in the management of Type 2 diabetes mellitus. These drugs can potentially decrease the risk of cardiovascular disease by correcting the different components of the insulin resistance syndrome.

Copyright information

© Humana Press Inc. 2002

Authors and Affiliations

  • Biswanath P. Gouda
    • 1
  • Sunil Asnani
    • 1
  • Vivian A. Fonseca
    • 1
  1. 1.Tulane Diabetes Program, Department of Medicine, Section of EndocrinologyTulane University Medical Center, SL-53New OrleansUSA